Xanthopsychia: Understanding Yellow‑Tinted Vision

What is Xanthopsychia?

Xanthopsychia (from the Greek xanthos = yellow and psychia = mind/vision) describes a visual disturbance in which the world appears tinted yellow. It is a type of chromatic aberration that can be transient or persistent, depending on the underlying cause. While a mild, temporary yellow hue may be harmless, persistent or worsening xanthopsychia often signals an ocular, neurological, or systemic problem that requires medical attention.

Common Causes

Many conditions can alter the wavelength of light reaching the retina or affect the brain’s processing of color. The most frequently reported causes include:

• Jaundice (hyperbilirubinemia) – excess bilirubin deposits in the sclera and retina, often seen in liver disease or hemolysis.
• Medication side‑effects – drugs such as quinine, digitalis, sildenafil, and certain antibiotics (e.g., chlorpromazine) can change color perception.
• Retinal disorders – macular degeneration, retinitis pigmentosa, or central serous chorioretinopathy can distort color signals.
• Optic neuritis – inflammation of the optic nerve, frequently linked to multiple sclerosis.
• Migraine aura – visual auras may include color shifts, including yellow tinting.
• Brain lesions – strokes, tumors, or traumatic injury affecting the occipital lobe or visual pathways.
• Vitamin A deficiency – impairs rod function and can cause abnormal color discrimination.
• Exposure to toxic chemicals – such as carbon tetrachloride or certain pesticides that damage retinal pigment epithelium.
• Age‑related cataracts – yellowish opacities in the lens scatter blue light, leaving a relative yellow hue.
• Psychiatric or neurological conditions – rare cases of hallucinations (e.g., Charles Bonnet syndrome) may include chromatic distortions.

Associated Symptoms

Because xanthopsychia can stem from diverse organ systems, it is often accompanied by other signs. Common co‑symptoms include:

• Yellowing of the skin or sclera (jaundice)
• Blurred or reduced visual acuity
• Glare or increased light sensitivity (photophobia)
• Headache or migraine aura
• Pain behind the eye or orbital pressure
• Double vision (diplopia)
• Eye redness, tearing, or discharge
• Neurological deficits – weakness, numbness, or speech changes (suggesting a central cause)
• Systemic symptoms – fatigue, nausea, abdominal pain (when liver disease is involved)
• Hallucinations or vivid visual phenomena (in psychiatric causes)

When to See a Doctor

While occasional color shifts can be benign, you should schedule an eye or primary‑care appointment if you notice any of the following:

• Yellow tint persists for more than 24 hours.
• Sudden onset of the symptom, especially if accompanied by headache, weakness, or speech changes.
• Associated jaundice, abdominal pain, or unexplained weight loss.
• Vision loss, new floaters, flashes of light, or a “curtain” over part of your visual field.
• Recent start or dosage change of a medication known to affect vision.
• History of eye disease (cataract, macular degeneration) with new color distortion.
• Any trauma to the head or eye.

Diagnosis

Diagnosing xanthopsychia is a stepwise process that combines a detailed history with targeted examinations.

1. Clinical History

Physicians will ask about:

• Onset, duration, and pattern of the yellow tint.
• Medication list (including over‑the‑counter and supplements).
• Recent infections, travel, or chemical exposures.
• Systemic symptoms (e.g., abdominal pain, fatigue, fever).
• Family history of liver disease, ocular disorders, or migraines.

2. Eye Examination

• Visual acuity test – determines how sharply you see.
• Slit‑lamp biomicroscopy – inspects the cornea, lens, and anterior chamber for cataracts or deposits.
• Fundus examination – evaluates retinal pigment, optic disc swelling, or macular changes.
• Color vision testing – Ishihara plates or Farnsworth‑Munsell tests can document specific deficits.

3. Laboratory Tests

• Complete metabolic panel (CMP) – assesses liver enzymes and bilirubin levels.
• Complete blood count (CBC) – looks for hemolysis or infection.
• Vitamin A level (if deficiency suspected).
• Autoimmune panels (ANA, anti‑MOG) when optic neuritis is a consideration.

4. Imaging

• Optical coherence tomography (OCT) – high‑resolution imaging of retinal layers.
• Magnetic resonance imaging (MRI) of the brain and orbits – identifies demyelination, tumors, or vascular lesions.
• CT scan – preferred for acute trauma or hemorrhage.

5. Specialized Tests

• Electroretinography (ERG) – measures retinal electrical response.
• Visual field testing – evaluates peripheral vision loss.

Treatment Options

Treatment is directed at the underlying cause. Below is a concise guide to the most common scenarios.

1. Liver‑Related Causes (Jaundice)

• Address the root disease – antiviral therapy for hepatitis, steroids for autoimmune hepatitis, or lifestyle changes for alcoholic liver disease.
• Phototherapy or exchange transfusion in severe neonatal hyperbilirubinemia.
• Hydration and avoidance of hepatotoxic substances (e.g., alcohol, certain supplements).

2. Medication‑Induced Changes

• Consult the prescribing physician about dose reduction or substitution.
• Monitor vision after medication changes; most drug‑related color shifts resolve within weeks.

3. Retinal or Optic Nerve Disorders

• Age‑related macular degeneration – anti‑VEGF injections, AREDS2 vitamin formulation.
• Optic neuritis – high‑dose intravenous methylprednisolone followed by oral taper (per Optic Neuritis Treatment Trial).
• Low‑vision rehabilitation for irreversible loss.

4. Migraine‑Related Aura

• Acute treatment with NSAIDs, triptans, or gepants.
• Preventive therapy (beta‑blockers, amitriptyline, CGRP monoclonal antibodies) if attacks are frequent.

5. Nutritional Deficiencies

• Vitamin A supplementation (usually 10,000 IU daily for 2–3 months) under medical supervision.
• Balanced diet rich in liver, dairy, and orange‑colored vegetables.

6. Cataract Management

• Early-stage cataracts: sunglasses with blue‑light filter, adequate lighting.
• Advanced cataracts: phacoemulsification with intra‑ocular lens implantation.

7. General Supportive Measures

• Regular eye‑exams (every 1–2 years, or sooner if symptoms arise).
• Avoid smoking and excessive alcohol, both of which accelerate cataract formation and liver disease.
• Stay hydrated and maintain a healthy weight to reduce systemic inflammation.

Prevention Tips

While not all causes are preventable, many risk factors are modifiable:

• Protect liver health: limit alcohol, maintain a balanced diet, vaccinate against hepatitis A & B, and manage diabetes.
• Medication vigilance: keep an updated list of drugs and ask your pharmacist about visual side‑effects.
• Eye safety: wear UV‑blocking sunglasses, use protective eyewear when handling chemicals or during sports.
• Regular screenings: annual dilated eye exams after age 40, and sooner if you have diabetes or a family history of eye disease.
• Healthy lifestyle: eat foods rich in lutein and zeaxanthin (leafy greens, egg yolks) to support macular health.
• Control blood pressure and cholesterol: reduces risk of vascular events that could affect visual pathways.

Emergency Warning Signs

---

References:

• Mayo Clinic. “Vision changes.” mayoclinic.org. Accessed May 2026.
• American Academy of Ophthalmology. “Color Vision Deficiency.” aao.org. 2024.
• National Institutes of Health. “Optic Neuritis Treatment Trial.” clinicaltrials.gov. 2023.
• World Health Organization. “Guidelines for the Management of Hepatitis B and C.” 2022.
• Cleveland Clinic. “Migraine Aura and Visual Symptoms.” clevelandclinic.org. 2023.
• U.S. Centers for Disease Control and Prevention. “Jaundice in Adults.” cdc.gov. 2022.